Tscan therapeutics announces 2023 clinical plans and highlights recent progress

Phase 1 umbrella trial of tsc-100 and tsc-101 active in five sites; on track to enroll first two cohorts in 1h 2023 with interim data by end of 2023
TCRX Ratings Summary
TCRX Quant Ranking